Cargando…

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study

Detalles Bibliográficos
Autores principales: Wang, Jiani, Liu, Yuwei, Zhang, Renzhi, Liu, Zhenyu, Yi, Zongbi, Guan, Xiuwen, Zhao, Xinming, Jiang, Jingying, Tian, Jie, Ma, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150865/
https://www.ncbi.nlm.nih.gov/pubmed/37027394
http://dx.doi.org/10.1097/CM9.0000000000002625
_version_ 1785035429411553280
author Wang, Jiani
Liu, Yuwei
Zhang, Renzhi
Liu, Zhenyu
Yi, Zongbi
Guan, Xiuwen
Zhao, Xinming
Jiang, Jingying
Tian, Jie
Ma, Fei
author_facet Wang, Jiani
Liu, Yuwei
Zhang, Renzhi
Liu, Zhenyu
Yi, Zongbi
Guan, Xiuwen
Zhao, Xinming
Jiang, Jingying
Tian, Jie
Ma, Fei
author_sort Wang, Jiani
collection PubMed
description
format Online
Article
Text
id pubmed-10150865
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101508652023-05-02 Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study Wang, Jiani Liu, Yuwei Zhang, Renzhi Liu, Zhenyu Yi, Zongbi Guan, Xiuwen Zhao, Xinming Jiang, Jingying Tian, Jie Ma, Fei Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-04-05 2023-03-28 /pmc/articles/PMC10150865/ /pubmed/37027394 http://dx.doi.org/10.1097/CM9.0000000000002625 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Wang, Jiani
Liu, Yuwei
Zhang, Renzhi
Liu, Zhenyu
Yi, Zongbi
Guan, Xiuwen
Zhao, Xinming
Jiang, Jingying
Tian, Jie
Ma, Fei
Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study
title Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study
title_full Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study
title_fullStr Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study
title_full_unstemmed Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study
title_short Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study
title_sort multi-omics fusion analysis models with machine learning predict survival of her2-negative metastatic breast cancer: a multicenter prospective observational study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150865/
https://www.ncbi.nlm.nih.gov/pubmed/37027394
http://dx.doi.org/10.1097/CM9.0000000000002625
work_keys_str_mv AT wangjiani multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT liuyuwei multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT zhangrenzhi multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT liuzhenyu multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT yizongbi multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT guanxiuwen multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT zhaoxinming multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT jiangjingying multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT tianjie multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy
AT mafei multiomicsfusionanalysismodelswithmachinelearningpredictsurvivalofher2negativemetastaticbreastcanceramulticenterprospectiveobservationalstudy